Prostate Cancer

PSA provocation by bipolar androgen therapy may predict duration of response to first-line androgen deprivation: Updated results from the BATMAN study. August 12, 2022

Diagnostic evaluation and incorporation of PSA density and the prostate imaging and data reporting system (PIRADS) version 2 classification in risk-nomograms for prostate cancer. August 12, 2022

The proportion of potential candidates for focal therapy in localized prostate cancer in a real-life cohort and their final pathologic results. August 12, 2022

Final analysis of the Magnetic Resonance Imaging in Active Surveillance (MRIAS) Trial. August 12, 2022

Race and prostate cancer: genomic landscape. August 12, 2022

Improving Patient Advocacy in NCI Scientific Steering Committees and Task Forces August 11, 2022

Assessing the accuracy of [18F]PSMA-1007 PET/CT for primary staging of lymph node metastases in intermediate- and high-risk prostate cancer patients. August 11, 2022

Patterns of structural variation define prostate cancer across disease states. August 11, 2022

Nightmares in Salvage Robot-assisted Radical Prostatectomy After Primary Radiation Therapy for Prostate Cancer: A Step by Step Tutorial. August 11, 2022

External validation of two mpMRI-risk calculators predicting risk of prostate cancer before biopsy. August 11, 2022

Biochemical relapse predictive factors in patients with lymph node metastases during radical prostatectomy. August 11, 2022

Chemotherapy and advanced androgen blockage, alone or combined, for metastatic hormone-sensitive prostate cancer a systematic review and meta-analysis. August 10, 2022

Systemic inflammatory biomarkers as predictive and prognostic factors in men with metastatic castration-refractory prostate cancer treated with docetaxel therapy: a comprehensive analysis in a German real-world cohort. August 10, 2022

Diabetes mellitus lowers the chance of short-term urinary continence recovery in prostate cancer patients undergoing radical prostatectomy. August 10, 2022

Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN). August 10, 2022

ACCURATE PREDICTION OF LONG-TERM RISK OF BIOCHEMICAL FAILURE AFTER SALVAGE RADIOTHERAPY INCLUDING THE IMPACT OF PELVIC NODE IRRADIATION. August 10, 2022

Different predictive values of microvessel density for biochemical recurrence among different PCa populations: A systematic review and meta-analysis. August 10, 2022

Avenda Health Receives FDA Investigational Device Exemption for AI-enabled Prostate Cancer Therapy August 9, 2022

Predictors and trends of opioid-sparing radical prostatectomy from a large national cohort. August 9, 2022

Satisfaction with Clinician-Led Germline Genetic Counseling in Patients with Prostate Cancer. August 9, 2022

Page 1 of 1241

email news signup